Showing results (191-200 of 258) with videos related to
Sort By:
Pageof 26
Journal of the National Cancer Institute|August 13, 1998
Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexesY Zou, G Zong, Y H Ling, et al.Ultramicroscopy|December 8, 2019
Quantifying oxygen distortions in lithium-rich transition-metal-oxide cathodes using ABF STEME Liberti, J G Lozano, M A Pérez Osorio, et al.The Journal of Pathology|July 27, 1999
Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null miceT J McDonnell, R Montes de Oca Luna, S Cho, et al.The Journal of Biological Chemistry|September 25, 1992
Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cellsH Goldberg, T Helaakoski, L A Garrett, et al.The International Journal of Biological Markers|July 5, 2003
Medullary breast carcinoma: prognostic implications of p53 expressionR Dendale, A Vincent-Salomon, E Mouret-Fourme, et al.Archives of Medical Research|January 1, 1992
Axenic massive cultivation of Entamoeba histolytica trophozoites in spinner flasks and in a microfermentorS Said-Fernández, B D Mata-Cárdenas, J Castro-Garza, et al.Biochemical and Biophysical Research Communications|July 30, 1999
The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53D Keller, X Zeng, X Li, et al.Cell Death and Differentiation|September 12, 2015
Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulationM Charni, A Molchadsky, I Goldstein, et al.Anales De Medicina Interna (Madrid, Spain : 1984)|January 19, 2000
[Antithrombotic treatment in non-rheumatic atrial fibrillation. Do we follow the recommendations of clinical trials?]J F Sánchez, L García, M Chiquero, et al.Lupus|June 4, 2011
Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patientsE G N Cavalcante, N E Aikawa, R G Lozano, et al.Pageof 26